Attached files
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Earliest Event Reported: August 23, 2011
CREENERGY CORPORATION
---------------------
(Exact name of registrant as specified in its charter)
Nevada 333-133347 98-0479983
----------------------------- -------------------- --------------------------
(State or other jurisdiction (Commission File (IRS Employer Identifica
of incorporation) Number) -tion Number)
601 Union Street, Two Union Square, 42nd Floor, Seattle, Washington 98101
-------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(780) 668-7422
----------------
Registrant's telephone number, including area code
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS
Item 1.01 Entry into a Material Definitive Agreement.
On August 23, 2011, CREEnergy Corporation ("the Company") entered into a Asset
Purchase with William Campbell and Scott McKinley to acquire intangible assets
and intellectual property known as the Peptide Technology Platform.
The Peptide Technology Platform includes the technology platforms for developing
a variety of drug candidates and biological solutions for existing problems in
humans, animals and the environment.
In exchange for such assets, the Company will issue 75,000,000 shares of its
restricted common stock to the owners of the technology. The closing of the
transaction is dependent upon the conclusion of due diligence by both parties
and the finalization of the agreement between both the Company and the owners of
the technology.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this Report to be signed on its behalf by the
undersigned, hereunto duly authorized.
CREENERGY CORPORATION
By: /s/ Shari Sookarookoff
------------------------------------
Shari Sookarookoff, CEO
Date: September 1, 2011